Form 4: Orthopediatrics Director Harold Ruf Boosts Stake with Restricted Stock Award

Orthopediatrics Corp. Director Harold Ruf has increased his beneficial ownership in the company by receiving 8,401 shares of common stock as a restricted stock award.

Summary

• Harold Ruf, a Director of Orthopediatrics Corp. (KIDS), reported a change in beneficial ownership via a Form 4 filing.
• On May 23, 2025, Mr. Ruf acquired 8,401 shares of Common Stock directly, which are identified as restricted stock awards with a transaction price of $0.
• Following this transaction, Mr. Ruf directly owns 8,401 shares.
• Additionally, Mr. Ruf indirectly holds 19,247 shares through The Last Chance Legacy Trust, dated April 3, 2023, where he serves as trustee and has a pecuniary interest; this includes 2,499 restricted stock awards.
• He also indirectly holds 2,400 shares through the Harald Ruf Roth IRA.
• The total beneficial ownership reported by Mr. Ruf after this transaction is 30,048 shares (8,401 direct + 19,247 indirect + 2,400 indirect).

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as it indicates a director increasing their stake in the company, aligning their interests with shareholders, even if it's a grant rather than an open market purchase. This suggests confidence in the company's future.

Positives

• The acquisition of 8,401 shares by Director Harold Ruf, even as a restricted stock award, indicates continued alignment of management interests with shareholder value.
• The grant of restricted stock awards is a common incentive mechanism to retain key personnel and motivate long-term performance.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing is a routine disclosure of insider stock ownership changes, common across all publicly traded companies. It reflects an internal compensation or incentive mechanism rather than a broader industry trend or competitive action.

Comparison to Industry Standards

• The grant of restricted stock awards to directors is a standard practice in corporate governance across various industries, including medical devices, to align director interests with long-term shareholder value.
• The disclosure format and content adhere to SEC regulations for Form 4 filings, consistent with reporting standards for companies like Stryker (SYK) or Zimmer Biomet (ZBH) in the orthopedic sector.

Related Party Transactions

• The shares held by The Last Chance Legacy Trust and Harald Ruf Roth IRA represent indirect beneficial ownership by the reporting person, which are standard disclosures for related party holdings under Section 16 regulations.

Stakeholder Impact

• Shareholders: The increase in director ownership through restricted stock awards can be viewed positively as it aligns the director's financial interests with the long-term performance of the company, potentially leading to more shareholder-friendly decisions.
• Employees: While not directly impacting employees, such grants are part of broader compensation strategies that can influence overall company culture and performance incentives.

Key Dates

Keywords

Orthopediatrics, KIDS, SEC Form 4, Insider Trading, Beneficial Ownership, Restricted Stock Award, Director Stock Acquisition, Equity Compensation, Corporate Governance